tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AIM Stock Latest News

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
Press ReleasesAIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
2d ago
AIM
AIM ImmunoTech completes cGMP manufacturing of clinical vials of Ampligen
PremiumThe Fly
AIM ImmunoTech completes cGMP manufacturing of clinical vials of Ampligen
2d ago
AIM
AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
PremiumPress Releases
AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
9d ago
AIM
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
PremiumThe Fly
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
9d ago
AIM
AZN
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
PremiumPress Releases
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
13d ago
AIM
AIM ImmunoTech files to sell 9.98M shares of common stock for holders
PremiumThe FlyAIM ImmunoTech files to sell 9.98M shares of common stock for holders
19d ago
AIM
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
PremiumPress Releases
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
20d ago
AIM
AIM ImmunoTech announces reslease of CEO Corner segment
PremiumThe Fly
AIM ImmunoTech announces reslease of CEO Corner segment
20d ago
AIM
AIM ImmunoTech appoints Lapp as a consulting Medical Officer
PremiumThe Fly
AIM ImmunoTech appoints Lapp as a consulting Medical Officer
23d ago
AIM
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
PremiumPress Releases
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
23d ago
AIM
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
PremiumPress Releases
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
27d ago
AIM
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
PremiumPress Releases
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
28d ago
AIM
AIM ImmunoTech announces interim report data from Ampligen study
PremiumThe FlyAIM ImmunoTech announces interim report data from Ampligen study
28d ago
AIM
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
1M ago
AIM
Navigating the Future: Aim Immunotech’s Challenge Against Rapid Tech Evolution in Pharma
PremiumCompany Announcements
Navigating the Future: Aim Immunotech’s Challenge Against Rapid Tech Evolution in Pharma
1M ago
AIM
AIM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AIM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
AIM
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
PremiumPress Releases
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
1M ago
AIM
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
PremiumPress Releases
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
1M ago
AIM
AIM ImmunoTech announces publication of findings from Ampligen study
PremiumThe Fly
AIM ImmunoTech announces publication of findings from Ampligen study
1M ago
AIM
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
PremiumPress ReleasesAIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
1M ago
AIM
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
PremiumPress Releases
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
2M ago
AIM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AIM
ALPN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >